Platelet Aggregation Devices Market
Global platelet aggregation devices market is estimated to be valued at USD 611.7 Mn in 2024 and is expected to exhibit a CAGR of 6.6% during the forecast period (2024-2031). Platelet aggregation devices are used in clinical settings to aid in diagnosis of platelet disorders. Platelets are essential for the blood clotting process, and any irregularities in their function can elevate the risk of bleeding or the formation of blood clots. Platelet aggregation devices help evaluate platelet function by measuring their ability to aggregate in response to different agonists. Technological advancements are allowing for automated, high-throughput testing with improved sensitivity and reproducibility. Due to its ability to aid in screening for platelet disorders and optimize antiplatelet therapy, there will be huge demand for platelet aggregation devices.
Market Dynamics
Platelet aggregation devices market growth is driven by growing incidence of cardiovascular diseases and associated increased use of antiplatelet drugs. Advanced features of newer devices are also improving workflow and easing the shift from manual to automated testing methods. However, market faces challenges like high costs of automated platelet analyzers as well as challenges to replace existing installed bases. Expanding applications such as monitoring antiplatelet therapy during pregnancy and developing standardized testing protocols for point-of-care use can offer growth opportunities.
Key features of the study
- This report provides in-depth analysis of the global platelet aggregation devices market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global platelet aggregation devices market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Sysmex Corporation, WerfenLife SA, Siemens Healthineers, Sentinel Ch. SpA, Haemonetics Corporation, Chrono-Log Corporation, Bio/Data Corporation, Aggredyne Inc., F. Hoffmann-La Roche Ltd., and Helena Laboratories Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global platelet aggregation devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global platelet aggregation devices market
Market Segmentation
Table of Contents
*Browse 32 market data tables and 28 figures on 'Platelet Aggregation Devices Market' - Global forecast to 2031
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
860519526
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
